Comment
doi: 10.1056/NEJMc2304776.
Treatment Strategy for Rifampin-Susceptible Tuberculosis
Affiliations
- PMID: 37314716
- DOI: 10.1056/NEJMc2304776
Item in Clipboard
Comment
Treatment Strategy for Rifampin-Susceptible Tuberculosis
N Engl J Med.
.
No abstract available
Comment on
-
Treatment Strategy for Rifampin-Susceptible Tuberculosis.N Engl J Med. 2023 Mar 9;388(10):873-887. doi: 10.1056/NEJMoa2212537. Epub 2023 Feb 20. N Engl J Med. 2023. PMID: 36808186 Free PMC article. Clinical Trial.
Similar articles
-
Treatment Strategy for Rifampin-Susceptible Tuberculosis.N Engl J Med. 2023 Jun 15;388(24):2297. doi: 10.1056/NEJMc2304776. N Engl J Med. 2023. PMID: 37314715 No abstract available.
-
Treatment Strategy for Rifampin-Susceptible Tuberculosis.N Engl J Med. 2023 Jun 15;388(24):2296-2297. doi: 10.1056/NEJMc2304776. N Engl J Med. 2023. PMID: 37314714 No abstract available.
-
Treatment Strategy for Rifampin-Susceptible Tuberculosis. Reply.N Engl J Med. 2023 Jun 15;388(24):2298. doi: 10.1056/NEJMc2304776. N Engl J Med. 2023. PMID: 37314717 No abstract available.
-
Rifampin. No longer just for tuberculosis.Postgrad Med. 1985 Feb 15;77(3):228-30. doi: 10.1080/00325481.1985.11698907. Postgrad Med. 1985. PMID: 3883331 Review. No abstract available.
-
Rifampin.Tuberculosis (Edinb). 2008 Mar;88(2):151-4. doi: 10.1016/S1472-9792(08)70024-6. Tuberculosis (Edinb). 2008. PMID: 18486058 Review. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
